Four people in Denmark who developed serious eye conditions after using popular weight-loss and diabetes drugs Wegovy and ...

While headlines about 'Ozempic face' warn that the rapid weight loss associated with GLP-1 drugs can prematurely age people's ...

More than 40 people sought reimbursement after they said they had developed a serious eye condition as a result of using the ...

The authority said it has received 43 claims from patients who believe they developed the condition known as NAION after ...

Four patients in Denmark will receive compensation after developing serious eye conditions from the weight-loss and diabetes ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Four patients in Denmark, who experienced vision loss after using Novo Nordisk’s popular weight-loss and diabetes drugs ...

MILLIONS of us are on them, and the rest of us are fat jab-curious, intrigued by the ‘miracle’ shots melting waistlines ...

A Novo Nordisk challenge has driven Regen Doctors to voluntarily discontinue compounded semaglutide product claims, adding to ...

An estimated 12 percent of U.S. adults are currently taking a GLP-1 drug, such as Ozempic or Wegovy, a KFF survey last week ...

Four Danish patients who experienced vision loss after using Novo Nordisk's Wegovy and Ozempic were awarded compensation ...